Portal de Periódicos da CAPES

Ventricular Assist Devices Today and Tomorrow

2010; Elsevier BV; Volume: 24; Issue: 4 Linguagem: Inglês

10.1053/j.jvca.2009.11.011

1532-8422

Christopher A. Thunberg, Brantley Gaitan, Francisco A. Arabía, Daniel J. Cole, Alina M. Grigore,

Cardiac pacing and defibrillation studies

THE NUMBER OF people worldwide with heart failure (HF) is increasing at an alarming pace. In the United States alone, there are approximately 5.3 million people who have HF, with a prevalence estimated at 10 per 1,000 in people over the age of 65. 1 Rosamond W. Flegal K. Furie K. et al. Heart disease and stroke statistics—2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008; 117: e25-e146 Crossref PubMed Scopus (2991) Google Scholar It is now estimated that there are 660,000 new cases of HF diagnosed every year for people over 45 years of age. In 2008, there were more than 1 million hospital admissions for HF at a cost of $34.8 billion. Currently, preventative measures, optimal medical therapy, and heart transplantation are not effectively reducing the overall morbidity and mortality of this syndrome.